0,834  0,003  Muscle relaxant
0,769  0,002  Dopamine D1 antagonist
0,769  0,004  5 Hydroxytryptamine release stimulant
0,764  0,016  Caspase 9 stimulant
0,729  0,009  Respiratory analeptic
0,721  0,003  Skeletal muscle relaxant
0,657  0,003  Alpha 2 adrenoreceptor antagonist
0,589  0,004  Dopamine agonist
0,581  0,027  15-Lipoxygenase inhibitor
0,550  0,003  Dopamine D2 agonist
0,576  0,034  Transcription factor NF kappa B inhibitor
0,544  0,005  Dopamine antagonist
0,563  0,025  Antiparkinsonian
0,548  0,010  CYP2D6 inhibitor
0,539  0,005  Alpha adrenoreceptor antagonist
0,536  0,004  Alpha 2a adrenoreceptor antagonist
0,550  0,018  Analeptic
0,562  0,035  Antineoplastic (lung cancer)
0,540  0,016  CYP2C19 inhibitor
0,519  0,008  Sigma receptor agonist
0,504  0,005  Dopamine D2 antagonist
0,525  0,028  Prostate cancer treatment
0,498  0,005  Antiparkinsonian, rigidity relieving
0,504  0,015  Cardiodepressant
0,492  0,021  Caspase 3 stimulant
0,481  0,013  Antineoplastic enhancer
0,483  0,015  DNA damaging
0,490  0,024  Spasmolytic
0,488  0,029  Antidepressant
0,523  0,068  Apoptosis agonist
0,491  0,037  Antineoplastic (colorectal cancer)
0,486  0,035  Antineoplastic (colon cancer)
0,458  0,008  Topoisomerase II inhibitor
0,452  0,009  Antineoplastic (squamous cell carcinoma)
0,461  0,018  Hypoxia-inducible factor 1 alpha inhibitor
0,466  0,026  12-Lipoxygenase inhibitor
0,440  0,005  Neurotrophic factor enhancer
0,437  0,006  Erectile dysfunction treatment
0,450  0,020  Antineoplastic (glioblastoma multiforme)
0,437  0,009  Male reproductive disfunction treatment
0,463  0,037  Mood disorders treatment
0,453  0,027  Antineoplastic (glioma)
0,428  0,005  Alpha 2b adrenoreceptor antagonist
0,477  0,060  Antineoplastic (breast cancer)
0,451  0,040  Stroke treatment
0,436  0,031  Antineoplastic (brain cancer)
0,414  0,011  Tubulin antagonist
0,428  0,038  CYP2D6 substrate
0,424  0,036  Antineoplastic (melanoma)
0,412  0,030  Antineoplastic (non-small cell lung cancer)
0,407  0,025  Antineoplastic (lymphoma)
0,437  0,056  Histamine release inhibitor
0,419  0,038  Hepatic disorders treatment
0,416  0,036  CYP1A2 substrate
0,403  0,023  Vasodilator
0,388  0,009  Tyrosine 3 hydroxylase inhibitor
0,395  0,024  Antimitotic
0,392  0,024  Psychostimulant
0,381  0,019  Cyclic AMP phosphodiesterase inhibitor
0,365  0,004  Dopamine D5 antagonist
0,443  0,083  Antineoplastic (solid tumors)
0,378  0,025  Pyruvate kinase inhibitor
0,412  0,059  CYP3A4 substrate
0,411  0,059  CYP2C9 substrate
0,355  0,007  Topoisomerase I inhibitor
0,349  0,005  Alpha 2c adrenoreceptor antagonist
0,401  0,063  Antileukemic
0,366  0,032  Antineoplastic (renal cancer)
0,375  0,050  Antineoplastic (ovarian cancer)
0,350  0,035  Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor
0,321  0,017  5 Hydroxytryptamine antagonist
0,319  0,019  Antineoplastic (carcinoma)
0,344  0,044  NOS2 expression inhibitor
0,303  0,005  5 Hydroxytryptamine 7 antagonist
0,339  0,042  Free radical scavenger
0,326  0,030  Abortion inducer
0,338  0,041  Antineoplastic (small cell lung cancer)
0,294  0,006  Dopamine D3 antagonist
0,301  0,013  Antiadrenergic
0,292  0,009  5 Hydroxytryptamine 1A antagonist
0,330  0,052  Antioxidant
0,317  0,043  Acute neurologic disorders treatment
0,302  0,029  Hepatoprotectant
0,319  0,046  Dyrk kinase inhibitor
0,287  0,014  Adrenaline antagonist
0,278  0,005  Alpha adrenoreceptor agonist
0,284  0,018  5 Hydroxytryptamine 2 antagonist
0,296  0,030  P-glycoprotein inhibitor
0,269  0,004  Antineoplastic alkaloid
0,271  0,008  Breast cancer-resistant protein inhibitor
0,314  0,052  Antiprotozoal (Trypanosoma)
0,262  0,005  Alpha tubulin antagonist
0,269  0,013  5 Hydroxytryptamine 2A antagonist
0,312  0,058  Antineoplastic (multiple myeloma)
0,273  0,021  Liver fibrosis treatment
0,287  0,039  5 Hydroxytryptamine 1E antagonist
0,263  0,016  LDLR expression enhancer
0,291  0,047  DNA synthesis inhibitor
0,297  0,054  Tumour necrosis factor alpha release inhibitor
0,268  0,025  Cholinergic
0,263  0,021  Genotoxic
0,295  0,055  Antiprotozoal (Leishmania)
0,280  0,045  Chemopreventive
0,248  0,015  Antitussive
0,312  0,081  Bone diseases treatment
0,249  0,019  Antiviral (Hepatitis B)
0,289  0,061  Antineoplastic (cervical cancer)
0,296  0,068  Radioprotector
0,231  0,004  Alpha 2 adrenoreceptor agonist
0,291  0,064  UGT1A9 substrate
0,250  0,029  Antiseptic
0,232  0,014  5 Hydroxytryptamine 1 antagonist
0,237  0,023  Acetylcholine antagonist
0,299  0,086  Antihypertensive
0,300  0,087  Vasodilator, coronary
0,236  0,024  Cholinergic antagonist
0,271  0,063  Antineoplastic (liver cancer)
0,238  0,031  Melanin inhibitor
0,223  0,018  Alpha 1 adrenoreceptor antagonist
0,274  0,069  Antihypercholesterolemic
0,233  0,032  Antiischemic, cerebral
0,223  0,026  CDC-like kinase 1 inhibitor
0,285  0,088  CYP3A4 inhibitor
0,281  0,085  Antiischemic
0,203  0,007  Beta tubulin antagonist
0,221  0,027  Acetylcholinesterase inhibitor
0,208  0,014  Topoisomerase II alpha inhibitor
0,245  0,052  Sedative
0,237  0,047  Pneumotoxic
0,290  0,102  Vasodilator, peripheral
0,253  0,065  Antineoplastic (sarcoma)
0,221  0,034  Lipid peroxidase inhibitor
0,309  0,124  TNF expression inhibitor
0,298  0,116  Immunosuppressant
0,204  0,025  DNA intercalator
0,235  0,057  Mutagenic
0,179  0,006  Phosphodiesterase 11A inhibitor
0,179  0,006  Phosphodiesterase XI inhibitor
0,187  0,014  Acetylcholine nicotinic antagonist
0,230  0,059  Anesthetic general
0,205  0,034  Uterine stimulant
0,180  0,010  CDC-like kinase 3 inhibitor
0,208  0,039  Acetylcholine M1 receptor antagonist
0,244  0,078  Superoxide dismutase inhibitor
0,237  0,073  Cytostatic
0,187  0,030  Alkylator
0,215  0,062  Nitric oxide antagonist
0,166  0,016  Prolactin inhibitor
0,158  0,009  Phosphodiesterase V inhibitor
0,288  0,144  Antibacterial
0,164  0,021  Antiviral (Papilloma)
0,181  0,040  Antifungal enhancer
0,193  0,055  UGT1A3 substrate
0,170  0,035  Adenylate cyclase stimulant
0,146  0,011  Phosphodiesterase 5A inhibitor
0,204  0,069  UGT1A1 substrate
0,146  0,013  Neuronal nicotinic receptor antagonist
0,180  0,048  Carcinogenic, group 1
0,181  0,050  UGT2B9 substrate
0,153  0,023  Alpha 1a adrenoreceptor antagonist
0,143  0,013  Restless leg syndrome treatment
0,191  0,065  UGT2B7 substrate
0,231  0,108  Cardioprotectant
0,192  0,069  VEGF expression inhibitor
0,138  0,018  Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor
0,157  0,038  5 Hydroxytryptamine 2B antagonist
0,254  0,135  Antiprotozoal (Plasmodium)
0,158  0,042  Cyclooxygenase 3 inhibitor
0,284  0,168  Alpha-glucosidase inhibitor
0,171  0,054  Antiparkinsonian, tremor relieving
0,139  0,024  5 Hydroxytryptamine agonist
0,191  0,076  UDP-glucuronosyltransferase substrate
0,199  0,086  Dependence treatment
0,116  0,003  Dopamine D1 agonist
0,221  0,108  Antipsychotic
0,262  0,153  Antiprotozoal
0,176  0,067  Antineoplastic (bone cancer)
0,118  0,009  5 Hydroxytryptamine 2A agonist
0,113  0,008  5 Hydroxytryptamine 2 agonist
0,121  0,017  Nicotinic alpha4beta2 receptor antagonist
0,120  0,020  ATPase (Vacuolar H+) inhibitor
0,137  0,036  Activin receptor-like kinase 4 inhibitor
0,161  0,061  Protein kinase stimulant
0,131  0,034  DOPA decarboxylase inhibitor
0,217  0,121  5 Hydroxytryptamine uptake stimulant
0,178  0,090  Amyloid beta aggregation inhibitor
0,115  0,027  Inducible nitric-oxide synthase inhibitor
0,093  0,005  Dopamine D5 agonist
0,146  0,060  Psychosexual dysfunction treatment
0,180  0,094  Proto-oncogene tyrosine-protein kinase Fyn inhibitor
0,129  0,045  Expectorant
0,154  0,070  Heat shock protein 90 antagonist
0,134  0,053  Papain-like protease (SARS coronavirus) inhibitor
0,135  0,054  Acetylcholine muscarinic antagonist
0,206  0,126  CYP2C19 substrate
0,162  0,082  ATPase inhibitor
0,193  0,114  Antipyretic
0,129  0,051  Microtubule formation inhibitor
0,084  0,007  Ryanodine receptor antagonist
0,085  0,008  Prolactin release inhibitor
0,181  0,104  Teratogen
0,095  0,018  Alpha 1 adrenoreceptor agonist
0,106  0,030  Opioid kappa receptor antagonist
0,101  0,026  HIV-1 integrase (3'-Processing) inhibitor
0,082  0,007  Factor III inhibitor
0,185  0,110  Antiamyloidogenic
0,135  0,061  Bipolar disorder treatment
0,149  0,075  Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor
0,106  0,033  Alpha 1b adrenoreceptor antagonist
0,096  0,023  Female sexual dysfunction treatment
0,134  0,061  Antismoking
0,123  0,050  Estrogen antagonist
0,133  0,061  M18 aspartyl aminopeptidase inhibitor
0,087  0,016  Heat shock protein 90 beta antagonist
0,081  0,011  5 Hydroxytryptamine 2C agonist
0,160  0,091  Toxic, respiratory center
0,157  0,088  UGT2B10 substrate
0,203  0,136  UGT2B4 substrate
0,107  0,040  Phosphodiesterase 6D inhibitor
0,141  0,075  MAP3K9 inhibitor
0,105  0,042  SULT1E1 substrate
0,110  0,047  Estrogen receptor beta antagonist
0,159  0,096  Platelet adhesion inhibitor
0,211  0,150  AR expression inhibitor
0,111  0,050  Obsessive-compulsive disorder treatment
0,115  0,057  Choleretic
0,081  0,023  5 Hydroxytryptamine 5A antagonist
0,082  0,025  Dopamine uptake inhibitor
0,086  0,028  HIV-1 integrase (Strand Transfer) inhibitor
0,184  0,129  Antihypotensive
0,095  0,040  mTOR complex 2 inhibitor
0,264  0,209  5 Hydroxytryptamine release inhibitor
0,072  0,018  5 Hydroxytryptamine 7 agonist
0,163  0,110  CYP2B6 inhibitor
0,199  0,146  Antihypoxic
0,070  0,017  Nicotinic receptor alpha4 subunit antagonist
0,070  0,017  Topoisomerase II beta inhibitor
0,073  0,020  Nicotinic receptor alpha7 subunit antagonist
0,190  0,137  Proliferative diseases treatment
0,089  0,037  Histidine decarboxylase inhibitor
0,158  0,107  Clk dual-specificity kinase inhibitor
0,173  0,123  Antineoplastic (lymphocytic leukemia)
0,069  0,018  Nicotinic alpha3beta2 receptor antagonist
0,081  0,032  Dopamine D4 antagonist
0,097  0,050  Opioid antagonist
0,106  0,060  Toll-Like receptor 4 antagonist
0,123  0,077  Antineoplastic (uterine cancer)
0,189  0,144  CYP1A2 inhibitor
0,082  0,038  Antitreponemal
0,070  0,026  5 Hydroxytryptamine 5 antagonist
0,192  0,149  Lipoxygenase inhibitor
0,171  0,129  VCAM1 expression inhibitor
0,157  0,115  Embryotoxic
0,148  0,107  Antineoplastic (gastric cancer)
0,111  0,072  Sphingosine 1-phosphate receptor 2 agonist
0,101  0,061  Butyrylcholinesterase inhibitor
0,195  0,160  Prostaglandin dehydrogenase inhibitor
0,179  0,144  Antiosteoporotic
0,077  0,042  Opioid mu receptor antagonist
0,079  0,044  Phosphodiesterase VI inhibitor
0,051  0,019  Phosphodiesterase 6C inhibitor
0,116  0,084  Amylase inhibitor
0,053  0,022  Opioid kappa receptor agonist
0,117  0,086  NADPH oxidase inhibitor
0,088  0,057  Calcium antagonist
0,133  0,103  Heat shock protein 70 antagonist
0,057  0,027  Dopamine transporter inhibitor
0,076  0,048  Glutamate decarboxylase inhibitor
0,064  0,038  Alpha 1d adrenoreceptor antagonist
0,106  0,079  Adenylate cyclase inhibitor
0,057  0,032  Opioid agonist
0,183  0,158  Radiosensitizer
0,094  0,070  Nitric-oxide synthase inhibitor
0,032  0,008  Endothelin B receptor antagonist
0,037  0,014  Endothelin receptor antagonist
0,051  0,028  Opioid mu receptor agonist
0,088  0,066  Antiviral (Hepatitis A)
0,055  0,033  Alpha-mannosidase inhibitor
0,044  0,022  Phenylethanolamine N methyltransferase inhibitor
0,075  0,054  Analgesic, opioid
0,136  0,115  Cytotoxic
0,075  0,056  Keratolytic
0,096  0,077  UGT2B1 substrate
0,074  0,058  Narcotic antagonist
0,132  0,118  Sensitization
0,211  0,197  Calcium channel activator
0,041  0,028  Plasmepsin II inhibitor
0,038  0,026  Vesicle monoamine transporter inhibitor
0,031  0,019  Phosphodiesterase 6B inhibitor
0,145  0,134  Antihypertriglyceridemic
0,072  0,061  GABA B receptor agonist
0,025  0,016  Dopamine autoreceptor agonist
0,023  0,014  Endothelin A receptor antagonist
0,193  0,185  CTGF expression inhibitor
0,066  0,059  Calcium channel L-type blocker
0,132  0,125  Tumour necrosis factor antagonist
0,024  0,017  Phosphodiesterase 6H inhibitor
0,024  0,017  Phosphodiesterase 6G inhibitor
0,071  0,065  Estrogen receptor alpha antagonist
0,041  0,035  Nicotinic receptor alpha3 subunit antagonist
0,105  0,099  Alcohol dehydrogenase substrate
0,203  0,199  Cognition disorders treatment
0,178  0,175  Antineoplastic (bladder cancer)
0,165  0,163  RNA-directed DNA polymerase inhibitor
0,059  0,057  Beta 3 adrenoreceptor antagonist
0,053  0,052  Opioid delta receptor antagonist

